On July 30, Quantinuum rose 6.61% in regular trading, trading at $51.62/share, with turnover of $13.37 million. The stock remains well below its $60 IPO price.

On the news front, since multiple Wall Street investment banks initiated coverage on June 29, the stock has experienced sustained wide-range oscillation driven by significant valuation divergence. The stock had previously fallen to approximately $47, marking a post-IPO low, and the current rebound represents a technical recovery within the oscillation range.

Among initiating banks, Rosenblatt issued the highest target at $155, while Morgan Stanley gave the most conservative view with an Equal-weight rating and $78 target. JPMorgan set a $97 target at Overweight, BofA and Needham both targeted $100, UBS targeted $93, and Mizuho, Jefferies, and Cantor Fitzgerald clustered around $90. The nearly 2x spread between the highest and lowest targets reflects deep disagreement over the quantum computing platform company's long-term commercial viability. The next earnings report is expected after market close on August 11.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)